Partner Don Schroeder was quoted in a Law 360 article, “EEOC Civility Training Pitch Could Leave Employers in a Bind,” covering the Equal Employment Opportunity Commission’s (EEOC) proposal to increase the implementation of “workplace civility training, which contradicts the National Labor Relations Board (NLRB) recent rulings against workplace civility rules.
Schroeder explained: “Cognitive dissonance [between the two agencies’ approaches] is probably an understatement. It’s an interesting confluence of guidance from one agency toward another.”
The article continues to discuss both the EEOC and NLRB’s positions, noting that employers may be unsure of how to proceed with these mixed messages. Schroeder adds that the EEOC’s proposal is not a mandate for employers and that it may be more likely that employers stick with “more traditional, annual anti-discrimination and anti-harassment trainings,” as a long-term solution to inappropriate workplace behavior.
Schroeder explained: “Cognitive dissonance [between the two agencies’ approaches] is probably an understatement. It’s an interesting confluence of guidance from one agency toward another.”
The article continues to discuss both the EEOC and NLRB’s positions, noting that employers may be unsure of how to proceed with these mixed messages. Schroeder adds that the EEOC’s proposal is not a mandate for employers and that it may be more likely that employers stick with “more traditional, annual anti-discrimination and anti-harassment trainings,” as a long-term solution to inappropriate workplace behavior.
People
Related News
13 February 2025
In the News
Gregory Husisian on USMCA Viability – 'The question is in what form?'
Foley & Lardner LLP partner Gregory Husisian assessed the viability of the U.S. – Mexico – Canada Agreement (USMCA) in the IndustryWeek article, “As Tariffs Concerns Grow, Where Is the USMCA?“
13 February 2025
In the News
Nikhil Pradhan on FDA Draft AI Drug Guidance – 'The industry is very much evolving'
Foley & Lardner LLP senior counsel Nikhil Pradhan shared insight on recent draft guidance from the U.S. Food and Drug Administration's in the MedCentral article, "FDA Draft Guidance Addresses Drug Submissions that Use AI Data."
12 February 2025
In the News